Muscular Dystrophy Clinical Trials in Kansas City, Kansas
8 recruitingKansas City, Kansas
Showing 1–8 of 8 trials
Recruiting
Phase 2
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
Duchenne Muscular DystrophyDMDNeuromuscular Diseases+2 more
Satellos Bioscience, Inc.51 enrolled25 locationsNCT07287189
Recruiting
Phase 2
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular DystrophyDMDExon 44
NS Pharma, Inc.20 enrolled25 locationsNCT05996003
Recruiting
Phase 1
Clenbuterol to Target DUX4 in FSHD
Muscular Dystrophy, Facioscapulohumeral
Jeffrey Statland30 enrolled3 locationsNCT06721299
Recruiting
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Muscular Dystrophy, Facioscapulohumeral
University of Kansas Medical Center80 enrolled7 locationsNCT06847282
Recruiting
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Duchenne Muscular Dystrophy
Catalyst Pharmaceuticals, Inc.250 enrolled27 locationsNCT06564974
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Muscular DystrophyLimb Girdle Muscular DystrophyLGMD2I+6 more
AskBio Inc10 enrolled6 locationsNCT05230459
Recruiting
Phase 1Phase 2
NS-050/NCNP-03 in Boys With DMD (Meteor50)
Duchenne Muscular Dystrophy
NS Pharma, Inc.20 enrolled18 locationsNCT06053814
Recruiting
LGMD R1 Natural History Study
Limb Girdle Muscular DystrophyLGMD2ACalpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A+1 more
Virginia Commonwealth University100 enrolled12 locationsNCT05618080